Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-14

Clinical Trial Update: Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adding SIMBRINZA (brinzolamide and timolol) to TRAVATAN Z (travoprost) for ocular hypertension and open-angle glaucoma; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMBRINZA Suspension (brinzolamide and timolol)
  • TRAVATAN Z (TRAVOPROST)

Snippet

Sponsor: Alcon Research | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2015-05-14